Investing News The FDA has given Sanofi’s hemophilia A drug BLA the Priority Review Status. August 30, 2022
Investing News Trxade Prime Plus Program by TRxADE Health Introduces Next-Day Delivery Options August 30, 2022
Investing News How Pfizer Emerged as the Winner in Bidding War for Global Blood Therapeuitcs August 24, 2022
Investing News Arrowhead Pharmaceuticals and Johnson & Johnson To Share Potentially Exciting News August 24, 2022
Investing News KalVista Hits Its Highest Point in Five Months, as Its Rival Drops Due to Hereditary Angioedema. August 22, 2022